Spatiotemporal immune landscape of colorectal cancer liver metastasis at single-cell level
Y Wu, S Yang, J Ma, Z Chen, G Song, D Rao, Y Cheng… - Cancer discovery, 2022 - AACR
Liver metastasis, the leading cause of colorectal cancer mortality, exhibits a highly
heterogeneous and suppressive immune microenvironment. Here, we sequenced 97 …
heterogeneous and suppressive immune microenvironment. Here, we sequenced 97 …
Liver immune microenvironment and metastasis from colorectal cancer-pathogenesis and therapeutic perspectives
Simple Summary Liver metastasis remains the major contributor in colorectal cancer-related
death. It has become clear that the unique immune features of liver microenvironment take …
death. It has become clear that the unique immune features of liver microenvironment take …
Enhancing HCC Treatment: innovatively combining HDAC2 inhibitor with PD-1/PD-L1 inhibition
R Han, C Ling, Y Wang, L Lu - Cancer Cell International, 2023 - Springer
Hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality but lacks
effective treatments thus far. Although the emergence of immune checkpoint inhibitors in …
effective treatments thus far. Although the emergence of immune checkpoint inhibitors in …
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases
KM Sullivan, X Jiang, P Guha, C Lausted, JA Carter… - Gut, 2023 - gut.bmj.com
Objective Programmed cell death protein 1 (PD-1) checkpoint inhibition and adoptive
cellular therapy have had limited success in patients with microsatellite stable colorectal …
cellular therapy have had limited success in patients with microsatellite stable colorectal …
Galectins as pivotal components in oncogenesis and immune exclusion in human malignancies
NI Kapetanakis, P Busson - Frontiers in Immunology, 2023 - frontiersin.org
Galectins are galactoside-binding proteins, exerting numerous functions inside and outside
the cell, particularly conferring adaptation to stress factors. For most of them, aberrant …
the cell, particularly conferring adaptation to stress factors. For most of them, aberrant …
From organoids to bedside: Advances in modeling, decoding and targeting of colorectal cancer
J Betge, R Jackstadt - International Journal of Cancer, 2023 - Wiley Online Library
Patient derived organoids closely resemble the biology of tissues and tumors. They are
enabling ex vivo modeling of human diseases and dissecting key features of tumor biology …
enabling ex vivo modeling of human diseases and dissecting key features of tumor biology …
Culture of vibrating microtome tissue slices as a 3D model in biomedical research
F Siwczak, C Hiller, H Pfannkuche… - Journal of biological …, 2023 - Springer
The basic idea behind the use of 3-dimensional (3D) tools in biomedical research is the
assumption that the structures under study will perform at the best in vitro if cultivated in an …
assumption that the structures under study will perform at the best in vitro if cultivated in an …
[HTML][HTML] Protocol for tissue slice cultures from human solid tumors to study therapeutic response
HL Kenerson, KM Sullivan, KP Labadie, VG Pillarisetty… - STAR protocols, 2021 - Elsevier
The impact of systemic therapy on the tumor microenvironment has been difficult to study in
human solid tumors. Our protocol describes steps for establishing slice cultures to …
human solid tumors. Our protocol describes steps for establishing slice cultures to …
Artificial tumor matrices and bioengineered tools for tumoroid generation
The tumor microenvironment (TME) is critical for tumor growth and metastasis. The TME
contains cancer-associated cells, tumor matrix, and tumor secretory factors. The fabrication …
contains cancer-associated cells, tumor matrix, and tumor secretory factors. The fabrication …
Metastable interface biomimetic synthesis of a smart nanosystem for enhanced starvation/gas therapy
M Zhai, P Gong, H Li, J Peng, W Xu, S Song… - Journal of Colloid and …, 2021 - Elsevier
Glucose oxidase (GOx)-mediated starvation therapy holds great promise in cancer
treatment. However, the worse hypoxia conditions result into low therapeutic efficiency, and …
treatment. However, the worse hypoxia conditions result into low therapeutic efficiency, and …